BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huo Z, Li C, Xu X, Ge F, Wang R, Wen Y, Peng H, Wu X, Liang H, Peng G, Li R, Huang D, Chen Y, Zhong R, Cheng B, Xiong S, Lin W, He J, Liang W. Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies. Oncoimmunology 2020;9:1848068. [PMID: 33299661 DOI: 10.1080/2162402X.2020.1848068] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Hazkani I, Hajnas N, Victor M, Stein E, Richardson A, Billings KR. Tonsillectomy Outcomes in Children After Solid‐Organ Transplantation: A 15‐Year Single‐Center Experience. Otolaryngol --head neck surg 2023. [DOI: 10.1002/ohn.193] [Reference Citation Analysis]
2 Christenson ES, Lee V, Wang H, Yarchoan M, De Jesus-Acosta A, Azad N, Gurakar A, Lin MT, Le DT, Brennan DC, Jaffee EM, Bever K. Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer. Curr Oncol 2022;30:75-84. [PMID: 36661655 DOI: 10.3390/curroncol30010006] [Reference Citation Analysis]
3 Babkina AV, Khubutiya MS. Development of oncological diseases after organ transplantation. Transplantologiâ (Mosk ) 2022;14:476-487. [DOI: 10.23873/2074-0506-2022-14-4-476-487] [Reference Citation Analysis]
4 Zhang Y, Lin J, You Z, Tu H, He P, Li J, Gao R, Liu Z, Xi Z, Li Z, Lu Y, Hu Q, Li C, Ge F, Huo Z, Qiao G. Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work? Front Immunol 2022;13:1050876. [PMID: 36605209 DOI: 10.3389/fimmu.2022.1050876] [Reference Citation Analysis]
5 Thet Z, Lam AK, Ng S, Aung SY, Han T, Ranganathan D, Newsham S, Borg J, Pepito C, Khoo TK. An integrated skin cancer education program in renal transplant recipients and patients with glomerular disease. BMC Nephrol 2022;23:361. [DOI: 10.1186/s12882-022-02997-z] [Reference Citation Analysis]
6 Ge F, Huo Z, Cai X, Hu Q, Chen W, Lin G, Zhong R, You Z, Wang R, Lu Y, Wang R, Huang Q, Zhang H, Song A, Li C, Wen Y, Jiang Y, Liang H, He J, Liang W, Liu J. Evaluation of Clinical and Safety Outcomes of Neoadjuvant Immunotherapy Combined With Chemotherapy for Patients With Resectable Esophageal Cancer. JAMA Netw Open 2022;5:e2239778. [DOI: 10.1001/jamanetworkopen.2022.39778] [Reference Citation Analysis]
7 Shen Y, Lian D, Shi K, Gao Y, Hu X, Yu K, Zhao Q, Feng C. Cancer Risk and Mutational Patterns Following Organ Transplantation. Front Cell Dev Biol 2022;10:956334. [DOI: 10.3389/fcell.2022.956334] [Reference Citation Analysis]
8 Wang X, Wu Y, Huang J, Shan S, Mai M, Zhu J, Yang M, Shang D, Wu Z, Lan J, Zhong S, Wu M. Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies. Front Pharmacol 2021;12:748609. [PMID: 34867352 DOI: 10.3389/fphar.2021.748609] [Reference Citation Analysis]
9 O'Connell KA, Schmults CD. Treatment of metastatic cutaneous squamous cell carcinoma in a solid organ transplant recipient with programmed death-1 checkpoint inhibitor therapy. J Eur Acad Dermatol Venereol 2022;36 Suppl 1:45-8. [PMID: 34855241 DOI: 10.1111/jdv.17407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Cangemi M, Zanussi S, Rampazzo E, Bidoli E, Giunco S, Tedeschi R, Pratesi C, Martorelli D, Casarotto M, Martellotta F, Schioppa O, Serraino D, Steffan A, De Rossi A, Dolcetti R, Vaccher E. Biological Predictors of De Novo Tumors in Solid Organ Transplanted Patients During Oncological Surveillance: Potential Role of Circulating TERT mRNA. Front Oncol 2021;11:772348. [PMID: 34746013 DOI: 10.3389/fonc.2021.772348] [Reference Citation Analysis]
11 Koseki Y, Kamimura K, Tanaka Y, Ohkoshi-Yamada M, Zhou Q, Matsumoto Y, Mizusawa T, Sato H, Sakamaki A, Umezu H, Yokoyama J, Terai S. Rapid progression of colonic mucinous adenocarcinoma with immunosuppressive condition: A case report and review of literature. World J Clin Cases 2021; 9(30): 9182-9191 [PMID: 34786403 DOI: 10.12998/wjcc.v9.i30.9182] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Kaźmierczak O, Kozaczka A, Kolonko A, Kajor M, Pająk J, Chudek J. Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report. Am J Case Rep 2021;22:e933267. [PMID: 34695070 DOI: 10.12659/AJCR.933267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Nikulin AV, Pashkov IV, Yakunin YS. Lung cancer in solid organ transplant recipients. RJTAO 2021;23:19-25. [DOI: 10.15825/25/1995-1191-2021-4-19-25] [Reference Citation Analysis]
14 Huo Z, Ge F, Li C, Cheng H, Lu Y, Wang R, Wen Y, Yue K, Pan Z, Peng H, Wu X, Liang H, He J, Liang W. Genetically predicted insomnia and lung cancer risk: a Mendelian randomization study. Sleep Med 2021;87:183-90. [PMID: 34627121 DOI: 10.1016/j.sleep.2021.06.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Nikulin AV, Pashkov IV, Yakunin YS. Post-transplant malignancies in solid organ recipients: development mechanisms and risk factors. RJTAO 2021;23:192-197. [DOI: 10.15825/1995-1191-2021-3-192-197] [Reference Citation Analysis]
16 Meyer F, Weil-Verhoeven D, Prati C, Wendling D, Verhoeven F. Safety of biologic treatments in solid organ transplant recipients: A systematic review. Semin Arthritis Rheum 2021;51:1263-73. [PMID: 34507811 DOI: 10.1016/j.semarthrit.2021.08.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]